Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6238 | 1509 | 37.3 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
116 | 3 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS | 70215 |
1239 | 2 | HETEROCYCLIC AMINES//HETEROCYCLIC AROMATIC AMINES//PHIP | 9032 |
6238 | 1 | ARYLAMINE N ACETYLTRANSFERASE//NAT2//N ACETYLTRANSFERASE | 1509 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ARYLAMINE N ACETYLTRANSFERASE | authKW | 1605497 | 6% | 85% | 93 |
2 | NAT2 | authKW | 1550035 | 9% | 58% | 131 |
3 | N ACETYLTRANSFERASE | authKW | 1473181 | 11% | 44% | 167 |
4 | N ACETYLTRANSFERASE 2 | authKW | 918855 | 5% | 64% | 71 |
5 | 2 AMINOFLUORENE | authKW | 621025 | 4% | 57% | 54 |
6 | NAT1 | authKW | 469465 | 2% | 63% | 37 |
7 | N ACETYL 2 AMINOFLUORENE | authKW | 345038 | 1% | 95% | 18 |
8 | ACETYLATION POLYMORPHISM | authKW | 332013 | 1% | 86% | 19 |
9 | N ACETYLTRANSFERASE 1 | authKW | 304342 | 1% | 79% | 19 |
10 | ACETYLATOR PHENOTYPE | authKW | 288019 | 1% | 65% | 22 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 5139 | 35% | 0% | 528 |
2 | Toxicology | 1989 | 11% | 0% | 173 |
3 | Oncology | 1547 | 18% | 0% | 274 |
4 | Genetics & Heredity | 490 | 9% | 0% | 133 |
5 | Biochemistry & Molecular Biology | 263 | 15% | 0% | 231 |
6 | Public, Environmental & Occupational Health | 118 | 5% | 0% | 76 |
7 | Medicine, Research & Experimental | 71 | 4% | 0% | 57 |
8 | Medical Laboratory Technology | 55 | 1% | 0% | 19 |
9 | Rheumatology | 35 | 1% | 0% | 18 |
10 | Chemistry, Medicinal | 33 | 2% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EA 1553 | 101169 | 0% | 100% | 5 |
2 | UMR7000 | 60701 | 0% | 100% | 3 |
3 | UFR BIOCHIM | 48928 | 1% | 16% | 15 |
4 | ENVIRONM GENOM INTEGRAT BIOL | 39229 | 1% | 24% | 8 |
5 | UNITE BIOL FONCT AD TAT | 28764 | 1% | 18% | 8 |
6 | MED TECHNOL OPTOMETRY | 26977 | 0% | 67% | 2 |
7 | POST BIOTECHNOL PROGRAM | 26977 | 0% | 67% | 2 |
8 | REPONSES MOL CELLULAI XENOBIOT | 26977 | 0% | 67% | 2 |
9 | UMR 7000 | 25593 | 1% | 14% | 9 |
10 | JAMES GRAHAM BROWN CANC | 22129 | 3% | 3% | 39 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOGENETICS | 123533 | 5% | 8% | 76 |
2 | CARCINOGENESIS | 7069 | 4% | 1% | 64 |
3 | DRUG METABOLISM AND DISPOSITION | 5640 | 3% | 1% | 46 |
4 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 4115 | 2% | 1% | 36 |
5 | PHARMACOGENETICS AND GENOMICS | 2992 | 1% | 1% | 13 |
6 | PHARMACOGENOMICS | 2897 | 1% | 1% | 16 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2703 | 2% | 0% | 31 |
8 | CURRENT DRUG METABOLISM | 2640 | 1% | 1% | 12 |
9 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1962 | 2% | 0% | 24 |
10 | BIOCHEMICAL PHARMACOLOGY | 1605 | 3% | 0% | 39 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARYLAMINE N ACETYLTRANSFERASE | 1605497 | 6% | 85% | 93 | Search ARYLAMINE+N+ACETYLTRANSFERASE | Search ARYLAMINE+N+ACETYLTRANSFERASE |
2 | NAT2 | 1550035 | 9% | 58% | 131 | Search NAT2 | Search NAT2 |
3 | N ACETYLTRANSFERASE | 1473181 | 11% | 44% | 167 | Search N+ACETYLTRANSFERASE | Search N+ACETYLTRANSFERASE |
4 | N ACETYLTRANSFERASE 2 | 918855 | 5% | 64% | 71 | Search N+ACETYLTRANSFERASE+2 | Search N+ACETYLTRANSFERASE+2 |
5 | 2 AMINOFLUORENE | 621025 | 4% | 57% | 54 | Search 2+AMINOFLUORENE | Search 2+AMINOFLUORENE |
6 | NAT1 | 469465 | 2% | 63% | 37 | Search NAT1 | Search NAT1 |
7 | N ACETYL 2 AMINOFLUORENE | 345038 | 1% | 95% | 18 | Search N+ACETYL+2+AMINOFLUORENE | Search N+ACETYL+2+AMINOFLUORENE |
8 | ACETYLATION POLYMORPHISM | 332013 | 1% | 86% | 19 | Search ACETYLATION+POLYMORPHISM | Search ACETYLATION+POLYMORPHISM |
9 | N ACETYLTRANSFERASE 1 | 304342 | 1% | 79% | 19 | Search N+ACETYLTRANSFERASE+1 | Search N+ACETYLTRANSFERASE+1 |
10 | ACETYLATOR PHENOTYPE | 288019 | 1% | 65% | 22 | Search ACETYLATOR+PHENOTYPE | Search ACETYLATOR+PHENOTYPE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOUKOUVALA, S , FAKIS, G , (2005) ARYLAMINE N-ACETYLTRANSFERASES: WHAT WE LEARN FROM GENES AND GENOMES.DRUG METABOLISM REVIEWS. VOL. 37. ISSUE 3. P. 511 -564 | 253 | 81% | 78 |
2 | SIM, E , ABUHAMMAD, A , RYAN, A , (2014) ARYLAMINE N-ACETYLTRANSFERASES: FROM DRUG METABOLISM AND PHARMACOGENETICS TO DRUG DISCOVERY.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 11. P. 2705 -2725 | 158 | 84% | 20 |
3 | HEIN, DW , DOLL, MA , FRETLAND, AJ , LEFF, MA , WEBB, SJ , XIAO, GH , DEVANOBOYINA, US , NANGJU, NA , FENG, Y , (2000) MOLECULAR GENETICS AND EPIDEMIOLOGY OF THE NAT1 AND NAT2 ACETYLATION POLYMORPHISMS.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 9. ISSUE 1. P. 29 -42 | 149 | 86% | 437 |
4 | SIM, E , LACK, N , WANG, CJ , LONG, H , WESTWOOD, I , FULLAM, E , KAWAMURA, A , (2008) ARYLAMINE N-ACETYLTRANSFERASES: STRUCTURAL AND FUNCTIONAL IMPLICATIONS OF POLYMORPHISMS.TOXICOLOGY. VOL. 254. ISSUE 3. P. 170-183 | 119 | 94% | 62 |
5 | HEIN, DW , (2006) N-ACETYLTRANSFERASE 2 GENETIC POLYMORPHISM: EFFECTS OF CARCINOGEN AND HAPLOTYPE ON URINARY BLADDER CANCER RISK.ONCOGENE. VOL. 25. ISSUE 11. P. 1649-1658 | 108 | 86% | 117 |
6 | SIM, E , WESTWOOD, I , FULLAM, E , (2007) ARYLAMINE N-ACETYLTRANSFERASES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 3. ISSUE 2. P. 169-184 | 106 | 84% | 35 |
7 | BUTCHER, NJ , MINCHIN, RF , (2012) ARYLAMINE N-ACETYLTRANSFERASE 1: A NOVEL DRUG TARGET IN CANCER DEVELOPMENT.PHARMACOLOGICAL REVIEWS. VOL. 64. ISSUE 1. P. 147 -165 | 132 | 57% | 23 |
8 | AGUNDEZ, JAG , (2008) POLYMORPHISMS OF HUMAN N-ACETYLTRANSFERASES AND CANCER RISK.CURRENT DRUG METABOLISM. VOL. 9. ISSUE 6. P. 520 -531 | 134 | 57% | 75 |
9 | WALKER, K , GINSBERG, G , HATTIS, D , JOHNS, DO , GUYTON, KZ , SONAWANE, B , (2009) GENETIC POLYMORPHISM IN N-ACETYLTRANSFERASE (NAT): POPULATION DISTRIBUTION OF NAT1 AND NAT2 ACTIVITY.JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS. VOL. 12. ISSUE 5-6. P. 440 -472 | 93 | 79% | 45 |
10 | FAKIS, G , BOUKOUVALA, S , VAGENA, E , (2008) ARYLAMINE N-ACETYLTRANSFERASES IN PROKARYOTIC AND EUKARYOTIC GENOMES: A SURVEY OF PUBLIC DATABASES.CURRENT DRUG METABOLISM. VOL. 9. ISSUE 7. P. 628 -660 | 129 | 62% | 7 |
Classes with closest relation at Level 1 |